Topol has led the flagship NIH-supported Scripps Translational Science Institute since 2006 and co-founded the West Wireless Health Institute. He is a professor of molecular medicine at The Scripps Research Institute and Chief Academic Officer of Scripps Health. Topol pioneered the development of many routinely used medications, including t-PA, Plavix, Angiomax, and ReoPro; he was the first physician to raise safety concerns about Vioxx. He has published 1100 peer-reviewed articles and over 30 medical textbooks.
In 2009, GQ named Topol one of the 12 "Rock Stars of Science." In 2011, the University of Michigan initiated the Eric Topol Professor of Cardiovascular Medicine. His alma mater, University of Rochester, awarded him its highest honor, the Hutchinson Medal. He was elected to the Institute of Medicine of the National Academy of Sciences and is one of the top 10 most cited researchers in medicine. His book The Creative Destruction of Medicine (Basic Books) was published in 2012.
Eric J. Topol, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Dexcom; Illumina; Molecular Stethoscope; Walgreens; Quest Diagnostics; MyoKardia
Received research grant from: National Institutes of Health
